Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mrityunjay C Metgud

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Lancet. Global Health|March 28, 2025
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trialJackie K Patterson, Simon Neuwahl, Sydney Kirsch, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 13, 2026
Intrapartum oral azithromycin for maternal infection prophylaxis and the risk of postpartum hemorrhage: A secondary analysis of the A-PLUS trialLarissa Sidze, Janet L Moore, Waldemar A Carlo, et al.
Lancet (London, England)|December 3, 2014
A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trialFernando Althabe, José M Belizán, Elizabeth M McClure, et al.
The New England Journal of Medicine|October 23, 2020
Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries, Olufemi T Oladapo, Joshua P Vogel, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Lancet. Global Health|March 28, 2025
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trialJackie K Patterson, Simon Neuwahl, Sydney Kirsch, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 13, 2026
Intrapartum oral azithromycin for maternal infection prophylaxis and the risk of postpartum hemorrhage: A secondary analysis of the A-PLUS trialLarissa Sidze, Janet L Moore, Waldemar A Carlo, et al.
Lancet (London, England)|December 3, 2014
A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trialFernando Althabe, José M Belizán, Elizabeth M McClure, et al.
The New England Journal of Medicine|October 23, 2020
Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries, Olufemi T Oladapo, Joshua P Vogel, et al.
Pageof 2